ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $92,000 | 0.0% | 4,275 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $92,000 | +46.0% | 4,275 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $63,000 | -34.4% | 4,275 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $96,000 | +47.7% | 4,275 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $65,000 | -5.8% | 4,275 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $69,000 | +187.5% | 4,275 | +533.3% | 0.01% | +133.3% |
| Q3 2019 | $24,000 | -36.8% | 675 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $38,000 | -22.4% | 675 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $49,000 | +14.0% | 675 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $43,000 | -14.0% | 675 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $50,000 | -9.1% | 675 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $55,000 | -21.4% | 675 | 0.0% | 0.01% | -27.3% |
| Q1 2018 | $70,000 | +2.9% | 675 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $68,000 | +15.3% | 675 | -60.3% | 0.01% | -15.4% |
| Q3 2017 | $59,000 | – | 1,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |